Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation
Aditya K. Padhi, Timir Tripathi
Topics & Concepts
TelaprevirBoceprevirProteaseComputational biologyBiologyDrugDrug discoveryVirologyHepatitis C virusVirusPharmacologyBioinformaticsBiochemistryRibavirinEnzymeComputational Drug Discovery Methodsvaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research